There are 2789 resources available
1666TiP - Phase II study of berzosertib (M6620) + topotecan in patients with relapsed platinum-resistant SCLC: DDRiver SCLC 250
Presenter: Anish Thomas
Session: ePoster Display
1650P - Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Presenter: David Chun Cheong Tsui
Session: ePoster Display
1641P - Patient preferences towards the application of telemedicine on cancer care during Coronavirus disease 2019 (COVID-19) pandemic. ONCOTELEMED STUDY
Presenter: Paula Ribera
Session: ePoster Display
1550P - A post hoc analysis of the EPAZ trial: The prognostic role of geriatric variables in elderly soft tissue sarcoma (STS) patients
Presenter: Rainer Hamacher
Session: ePoster Display
608P - Apalutamide (APA) efficacy and safety in Asian patients with metastatic castration-sensitive prostate cancer (mCSPC)
Presenter: Byung Ha Chung
Session: ePoster Display
609P - Treatment patterns and overall survival (OS) in metastatic castration-sensitive prostate cancer (mCSPC) from 2006 to 2019
Presenter: Stephen Freedland
Session: ePoster Display
611P - Pembrolizumab (pembro) monotherapy for docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): Updated analyses with 4 years of follow-up from cohorts 1-3 of the KEYNOTE-199 study
Presenter: Emmanuel Antonarakis
Session: ePoster Display